Literature DB >> 14745005

A pituitary gene encodes a protein that produces differentiation of breast and prostate cancer cells.

Micsunica Platica1, Elena Ivan, James F Holland, Alin Ionescu, Sheryl Chen, John Mandeli, Pamela D Unger, Ovidiu Platica.   

Abstract

A cDNA clone of 1.1 kb encoding a 108-aa polypeptide was isolated from a human pituitary cDNA library by expression cloning. This protein was named tumor differentiation factor (TDF). The recombinant TDF protein and a 20-aa peptide, P1, selected from the ORF of the gene, induced morphological and biochemical changes consistent with differentiation of human breast and prostate cancer cells. Fibroblast, kidney, hepatoma, and leukemic lymphocytic cell lines were unaffected. Breast and prostate cancer cells aggregated in spheroid-like structures within 24 h of exposure to TDF. This effect was abrogated by a specific affinity-purified rabbit polyclonal anti-P1 Ab. E-cadherin expression was increased in a dose-dependent manner by TDF. Treatment of MCF7 cells with TDF led to production of a lactalbumin-related protein. Peptide P1 significantly decreased the growth of androgen-independent DU145 prostate cancer in severe combined immunodeficient mice. The presence of TDF protein in human sera was detected by the anti-P1 Ab, suggesting a role of TDF in endocrine metabolism. The fact that all activities of TDF can be mimicked by a peptide derived from the encoding TDF sequence opens the possibility of therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745005      PMCID: PMC341774          DOI: 10.1073/pnas.0307829100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Estrogen and related compounds: biphasic dose responses.

Authors:  E J Calabrese
Journal:  Crit Rev Toxicol       Date:  2001-07       Impact factor: 5.635

Review 2.  Cell adhesion proteins as tumor suppressors.

Authors:  Takatsugu Okegawa; Yingming Li; Rey-Chen Pong; Jer-Tsong Hsieh
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

3.  Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas.

Authors:  T Mikami; M Saegusa; H Mitomi; N Yanagisawa; M Ichinoe; I Okayasu
Journal:  Am J Clin Pathol       Date:  2001-09       Impact factor: 2.493

4.  Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.

Authors:  Rex C Haydon; Lan Zhou; Tao Feng; Benjamin Breyer; Hongwei Cheng; Wei Jiang; Akira Ishikawa; Terrance Peabody; Anthony Montag; Michael A Simon; Tong-Chuan He
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

5.  Adriamycin activates E-cadherin-mediated cell-cell adhesion in human breast cancer cells.

Authors:  S Z Yang; N Kohno; K Kondo; A Yokoyama; H Hamada; K Hiwada; M Miyake
Journal:  Int J Oncol       Date:  1999-12       Impact factor: 5.650

6.  Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.

Authors:  C Sittel; H E Eckel; M Damm; E von Pritzbuer; H M Kvasnicka
Journal:  Laryngoscope       Date:  2000-06       Impact factor: 3.325

7.  Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate.

Authors:  M G Rashid; M G Sanda; C J Vallorosi; J Rios-Doria; M A Rubin; M L Day
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

8.  The differentiating effect of retinoic acid and vincristine on acute myeloid leukemia.

Authors:  M F Leung; K F Wong
Journal:  J Hematother       Date:  1999-06

9.  Low PSA metastatic androgen- independent prostate cancer.

Authors:  A Sella; M Konichezky; D Flex; A Sulkes; J Baniel
Journal:  Eur Urol       Date:  2000-09       Impact factor: 20.096

10.  Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer.

Authors:  J Cai; M Ikeguchi; S Tsujitani; M Maeta; J Liu; N Kaibara
Journal:  Gastric Cancer       Date:  2001       Impact factor: 7.370

View more
  3 in total

1.  Identification of potential tumor differentiation factor (TDF) receptor from steroid-responsive and steroid-resistant breast cancer cells.

Authors:  Izabela Sokolowska; Alisa G Woods; Mary Ann Gawinowicz; Urmi Roy; Costel C Darie
Journal:  J Biol Chem       Date:  2011-11-30       Impact factor: 5.157

Review 2.  Characterization of tumor differentiation factor (TDF) and its receptor (TDF-R).

Authors:  Izabela Sokolowska; Alisa G Woods; Mary Ann Gawinowicz; Urmi Roy; Costel C Darie
Journal:  Cell Mol Life Sci       Date:  2012-10-18       Impact factor: 9.261

3.  Structural evaluation and analyses of tumor differentiation factor.

Authors:  Urmi Roy; Alisa G Woods; Izabela Sokolowska; Costel C Darie
Journal:  Protein J       Date:  2013-10       Impact factor: 2.371

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.